{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:43:02Z","timestamp":1790210582283,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T00:00:00Z","timestamp":1680998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ebiom.2023.104585","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:56:14Z","timestamp":1683093374000},"page":"104585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Mucosal vaccines for SARS-CoV-2: triumph of hope over experience"],"prefix":"10.1016","volume":"92","author":[{"given":"Devaki","family":"Pilapitiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1064-3934","authenticated-orcid":false,"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2023.104585_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/mi.2008.5","article-title":"Mucins in the mucosal barrier to infection","volume":"1","author":"Linden","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ebiom.2023.104585_bib2","first-page":"299","article-title":"Importance of innate mucosal immunity and the promises it holds","volume":"4","author":"Dwivedy","year":"2011","journal-title":"Int J Gen Med"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104585_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1513\/pats.200508-089JS","article-title":"Humoral immune defense (antibodies): recent advances","volume":"2","author":"Twigg","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104585_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0025-6196(12)64949-0","article-title":"Immunoglobulin G and its function in the human respiratory tract","volume":"63","author":"Reynolds","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ebiom.2023.104585_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral evasion of the complement system and its importance for vaccines and therapeutics","volume":"11","author":"Mellors","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104585_bib6","first-page":"1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","author":"Zhang","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104585_bib7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.10.052","article-title":"Compromised humoral functional evolution tracks with SARS-CoV-2 mortality","volume":"183","author":"Zohar","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-019-13992-8","article-title":"IgA subclasses have different effector functions associated with distinct glycosylation profiles","volume":"11","author":"Steffen","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104585_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/mi.2011.39","article-title":"Structure and function relationships in IgA","volume":"4","author":"Woof","year":"2011","journal-title":"Mucosal Immunol"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104585_bib10","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.1503885112","article-title":"Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus","volume":"112","author":"Suzuki","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/171.1.198","article-title":"Parenteral influenza vaccination induces a rapid systemic and local immune response","volume":"171","author":"Brokstad","year":"1995","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104585_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104585_bib13","article-title":"A\u00a0single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41541-022-00509-6","article-title":"Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2","volume":"7","author":"Tioni","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104585_bib15","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A\u00a0live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci Bull"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104585_bib16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/ni.2745","article-title":"Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells","volume":"14","author":"Skon","year":"2013","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104585_bib17","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104585_bib18","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220780","article-title":"SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity","volume":"219","author":"Lim","year":"2022","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104585_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam6970","article-title":"Resident memory CD8(+) T cells in the upper respiratory tract prevent pulmonary influenza virus infection","volume":"2","author":"Pizzolla","year":"2017","journal-title":"Sci Immunol"},{"issue":"6205","key":"10.1016\/j.ebiom.2023.104585_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"T\u00a0cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2023.104585_bib21","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.3389\/fimmu.2018.02394","article-title":"CD4+ memory T cells at home in the tissue: mechanisms for health and disease","volume":"9","author":"Schreiner","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104585_bib22","first-page":"21","article-title":"Role of iBALT in respiratory immunity","volume":"426","author":"Silva-Sanchez","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104585_bib23","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.4049\/jimmunol.1102243","article-title":"Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection","volume":"187","author":"Teijaro","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104585_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2014.09.007","article-title":"CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection","volume":"41","author":"Laidlaw","year":"2014","journal-title":"Immunity"},{"issue":"55","key":"10.1016\/j.ebiom.2023.104585_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb6852","article-title":"Tissue-resident CD4(+) T helper cells assist the development of protective respiratory B and CD8(+) T cell memory responses","volume":"6","author":"Son","year":"2021","journal-title":"Sci Immunol"},{"issue":"55","key":"10.1016\/j.ebiom.2023.104585_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb6808","article-title":"T\u00a0resident helper cells promote humoral responses in the lung","volume":"6","author":"Swarnalekha","year":"2021","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","article-title":"The establishment of resident memory B cells in the lung requires local antigen encounter","volume":"20","author":"Allie","year":"2019","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104585_bib28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.immuni.2022.03.003","article-title":"Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites","volume":"55","author":"MacLean","year":"2022","journal-title":"Immunity"},{"issue":"67","key":"10.1016\/j.ebiom.2023.104585_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf5314","article-title":"Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles","volume":"7","author":"Tan","year":"2022","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104585_bib30","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.1115369109","article-title":"Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection","volume":"109","author":"Onodera","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104585_bib31","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.immuni.2022.06.002","article-title":"Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism","volume":"55","author":"Gregoire","year":"2022","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104585_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"issue":"65","key":"10.1016\/j.ebiom.2023.104585_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl9105","article-title":"SARS-CoV-2 infection generates tissue-localized immunological memory in humans","volume":"6","author":"Poon","year":"2021","journal-title":"Sci Immunol"},{"issue":"76","key":"10.1016\/j.ebiom.2023.104585_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104585_bib35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib36","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1038\/s41467-021-23333-3","article-title":"Peripheral and lung resident memory T cell responses against SARS-CoV-2","volume":"12","author":"Grau-Exposito","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104585_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.782421","article-title":"Respiratory mucosal immunity: kinetics of secretory immunoglobulin A in sputum and throat swabs from COVID-19 patients and vaccine recipients","volume":"13","author":"Ren","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of previous infection and vaccination on symptomatic Omicron infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10379","key":"10.1016\/j.ebiom.2023.104585_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","article-title":"Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis","volume":"401","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104585_bib40","article-title":"Observed protection against SARS-CoV-2 reinfection following a primary infection: a Danish cohort study among unvaccinated using two years of nationwide PCR-test data","volume":"20","author":"Michlmayr","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104585_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(22)00143-8","article-title":"Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden","volume":"22","author":"Nordstrom","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104585_bib42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ebiom.2023.104585_bib43","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa2207082","article-title":"Protection against Omicron from vaccination and previous infection in a prison system","volume":"387","author":"Chin","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104585_bib44","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104585_bib45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.immuni.2023.02.017","article-title":"SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses","volume":"56","author":"Koutsakos","year":"2023","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104585_bib46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS-CoV-2 Omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104585_bib47","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41591-022-01816-0","article-title":"Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2","volume":"28","author":"Puhach","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib48","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1038\/s41467-022-33096-0","article-title":"Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection","volume":"13","author":"Woodbridge","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104585_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41591-022-02138-x","article-title":"Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave","volume":"29","author":"Tan","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104585_bib50","article-title":"Infection-induced immunity is associated with protection against SARS-CoV-2 infection and decreased infectivity","volume":"074","author":"Frutos","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104585_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104585_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104402","article-title":"SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination","volume":"87","author":"Liew","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104585_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: from bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104585_bib54","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","article-title":"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"10","author":"Zhu","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2023.104585_bib55","series-title":"Meissa announces positive preliminary clinical data on safety and immunogenicity of intranasal COVID","year":"2021"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104585_bib56","article-title":"A\u00a0Newcastle disease virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine","volume":"8","author":"Sun","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib57","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41467-021-26499-y","article-title":"A\u00a0Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses","volume":"12","author":"Sun","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104585_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103132","article-title":"Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate","volume":"62","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104585_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791764","article-title":"Safety and immunogenicity analysis of a Newcastle disease virus (NDV-HXP-S) expressing the spike protein of SARS-CoV-2 in sprague dawley rats","volume":"12","author":"Tcheou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104585_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101323","article-title":"Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: interim results of a randomised, placebo-controlled, phase 1 trial","volume":"45","author":"Pitisuttithum","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ebiom.2023.104585_bib61","article-title":"Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: interim results of a non-randomized open label phase I trial in Mexico","author":"Ponce-de-Leon","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.ebiom.2023.104585_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"issue":"10269","key":"10.1016\/j.ebiom.2023.104585_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104585_bib64","series-title":"Altimmune announces update on AdCOVID\u2122 phase 1 clinical trial","year":"2021"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104585_bib65","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104585_bib66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","article-title":"Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A\u00a0single-dose intranasal Chad vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2023.104585_bib68","article-title":"Immunogenicity and tolerability of BBV154 (iNCOVACC\u00ae), an intranasal SARS-CoV-2 vaccine, compared with intramuscular Covaxin\u00ae in healthy adults: a randomised, open-label, Phase 3 Clinical Trial","author":"Singh","year":"2023","journal-title":"SSRN"},{"issue":"10344","key":"10.1016\/j.ebiom.2023.104585_bib69","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0140-6736(22)00484-6","article-title":"Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104585_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151463","article-title":"Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination","volume":"6","author":"Cagigi","year":"2021","journal-title":"JCI Insight"},{"issue":"6622","key":"10.1016\/j.ebiom.2023.104585_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"issue":"6549","key":"10.1016\/j.ebiom.2023.104585_bib72","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"issue":"6549","key":"10.1016\/j.ebiom.2023.104585_bib73","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.abh1282","article-title":"Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose","volume":"372","author":"Reynolds","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104585_bib74","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104585_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41577-022-00678-4","article-title":"Milder disease with Omicron: is it the virus or the pre-existing immunity?","volume":"22","author":"Sigal","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2023.104585_bib76","series-title":"AstraZeneca provides update on Flumist Quadrivalent Vaccine in the US for the 2016-17 influenza season","year":"2016"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104585_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/jcm.23.1.66-72.1986","article-title":"Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine","volume":"23","author":"Clements","year":"1986","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104585_bib78","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/21645515.2017.1377376","article-title":"Immune responses after live attenuated influenza vaccination","volume":"14","author":"Mohn","year":"2018","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104585_bib79","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/infdis\/jiw230","article-title":"Live attenuated influenza vaccine in children induces B-cell responses in tonsils","volume":"214","author":"Mohn","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104585_bib81","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2094","article-title":"Live attenuated and inactivated influenza vaccine effectiveness","volume":"143","author":"Chung","year":"2019","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104585_bib82","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014-2015 influenza vaccine effectiveness in the United States by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104585_bib83","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2018.01.016","article-title":"Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season","volume":"36","author":"King","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104585_bib84","article-title":"Nasal nanovaccines for SARS-CoV-2 to address COVID-19","volume":"10","author":"Huang","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"7929","key":"10.1016\/j.ebiom.2023.104585_bib85","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","article-title":"Long-primed germinal centres with enduring affinity maturation and clonal migration","volume":"609","author":"Lee","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2023.104585_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108782","article-title":"Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults","volume":"229","author":"Tamminen","year":"2021","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104585_bib87","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01967-21","article-title":"Serological follow-up study indicates high seasonal coronavirus infection and reinfection rates in early childhood","volume":"10","author":"Kolehmainen","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104585_bib88","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/infdis\/jiaa392","article-title":"Direct observation of repeated infections with endemic coronaviruses","volume":"223","author":"Galanti","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"23","key":"10.1016\/j.ebiom.2023.104585_bib89","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2018.04.063","article-title":"Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis","volume":"36","author":"Somes","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104585_bib90","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2021.01.045","article-title":"A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas","volume":"39","author":"Blunck","year":"2021","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104585_bib91","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2666-5247(21)00180-4","article-title":"Immune-mediated attenuation of influenza illness after infection: opportunities and challenges","volume":"2","author":"Patel","year":"2021","journal-title":"Lancet Microbe"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:25:02Z","timestamp":1762457102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":90,"alternative-id":["S2352396423001500"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104585","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal vaccines for SARS-CoV-2: triumph of hope over experience","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104585"}}